Intriguingly, the majority of CD8+ T cells in the bone marrow of AML patients expressed Siglec-7, with high co-expression of CTLA4, but lower expression of other inhibitory receptors (PD1, LAG3, BTLA, TIM3). This evidence concerns the gene BTLA and acute myeloid leukemia.